Subscribe: Market Wire - Medical and Healthcare: Medical Devices
http://img.marketwire.com/rss/mwMHMD.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
cfn media  clinical  company  marketwired oct  marketwired october  marketwired  media  medical  new  oct  october  webinar 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices



Marketwired - Medical Devices



Last Build Date: Thu, 19 Oct 2017 16:46:16 EDT

Copyright: Copyright: (C) Marketwired
 



Rand Capital Announces Third Quarter 2017 Financial Results Conference Call and Webcast

Thu, 19 Oct 2017 16:15:00 EDT

BUFFALO, NY--(Marketwired - October 19, 2017) - Rand Capital Corporation (NASDAQ: RAND) ("Rand"), a venture capital company which invests in growth businesses with unique product, service or technology concepts, announced today that it will release its third quarter 2017 financial results before the opening of financial markets on Monday, November 6, 2017.




UPDATE - HempAmericana, Inc. (OTC PINK: HMPQ) Filed its Financial Statements This Week for the Quarter Ending August 31, 2017

Thu, 19 Oct 2017 13:05:58 EDT

NEW YORK, NY--(Marketwired - Oct 19, 2017) - HempAmericana, Inc. (OTC PINK: HMPQ) filed its financial statements this week for the quarter ending August 31, 2017. The company achieved many milestones during the quarter. It raised $320,000 from its Regulation A offering, placed a down payment on a 200-liter extraction machine (lease to own), and formed Hempwerk, Inc., the conduit for its Maine operations. Subsequent to the quarter's end, HMPQ raised an additional $200,000 from the Regulation A offering. As the company continues to seek expansion, it is still actively courting investors for its Regulation A offering, set to expire at the end of March 2018. The company also recently visited a pilot hemp farm in Goshen, NY as it hopes to eventually set up operations in New York State and is actively exploring opportunities for industrial hemp production and products.




HempAmericana, Inc. (OTC PINK: HMPQ) Filed its Financial Statements This Week for the Quarter Ending August 31, 2017

Thu, 19 Oct 2017 11:16:55 EDT

NEW YORK, NY--(Marketwired - Oct 19, 2017) - HempAmericana, Inc. (OTC PINK: HMPQ) filed its financial statements this week for the quarter ending August 31, 2017. The company achieved many milestones during the quarter. It raised $320,000 from its Regulation A offering, placed a down payment on a 200-liter extraction machine (lease to own), and formed Hempwerk, Inc., the conduit for its Maine operations. Subsequent to the quarter's end, HMPQ raised an additional $200,000 from the Regulation A offering. As the company continues to seek expansion, it is still actively courting investors for its Regulation A offering, set to expire at the end of March 2018. The company also recently visited a pilot hemp farm in Goshen, NY as it hopes to eventually set up operations in New York State and is actively exploring opportunities for industrial hemp production and products.




Rennova Health's Big South Fork Medical Center Is Granted Three Year Certificate of Accreditation by CMS

Thu, 19 Oct 2017 09:20:00 EDT

WEST PALM BEACH, FL--(Marketwired - October 19, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that Big South Fork Medical Center, has been found to comply with the requirements of the NIAHO Hospital Accreditation Program, and has been awarded full accreditation for a three year term effective as of October 11, 2017.




RenalGuard's Ability to Prevent Contrast-Induced Acute Kidney Injury to be Showcased at TCT 2017

Thu, 19 Oct 2017 09:05:46 EDT

MILFORD, MA--(Marketwired - October 19, 2017) - Use of the RenalGuard® System to prevent acute kidney injury during cardiac interventions will be showcased as part of a satellite program entitled "Contrast-Induced Acute Kidney Injury: Preventive Measures that Work" at Transcatheter Cardiovascular Therapeutics 2017 (TCT 2017). TCT, the world's largest and most important educational meeting specializing in interventional cardiovascular medicine, is being held in Denver, Colorado from October 29 to November 2.




Dewmar Invests in Opportunities within $2.2 Trillion Entertainment Industry, Plus Exclusive CEO Interview -- CFN Media

Thu, 19 Oct 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Oct 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Dewmar International BMC Inc.'s (OTC PINK: DEWM) investments in cannabis-related entertainment projects. CFN Media also interviews the company's CEO, Dr. Marco Moran, about the company's variety of business initiatives in the cannabis, hemp, health, consumer products and entertainment industries.




VirtualHealth Expert to Speak About Caring for Socially Vulnerable Populations at Texas Association of Health Plans (TAHP) Conference

Thu, 19 Oct 2017 09:00:00 EDT

NEW YORK, NY--(Marketwired - Oct 19, 2017) - VirtualHealth, the leading provider of population health and care management technologies, announced today that its Executive Vice President of Client Services, Sheela Ramamurthy, will participate in a panel discussion, "Caring for Socially Vulnerable Populations: Emerging Trends and Practices in Effective Management," as part of the TAHP Managed Care Conference and Trade Show. On October 25 from 10-10:50 a.m., Ramamurthy will discuss the role of social determinants in caring for at-risk patient populations and the value of innovative models and solutions addressing their unique social and medical needs.




mCig to Spin-Off Technology Division as a Stand-Alone Public Company

Thu, 19 Oct 2017 08:30:00 EDT

LAS VEGAS, NV--(Marketwired - Oct 19, 2017) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, announced today that the company will spin-off its technology division as a stand-alone public company. In conjunction with the spin-off, mCig shareholders will be awarded shares in the proposed public entity based on their holdings in MCIG. mCig Inc. expects to file the appropriate documents with the SEC within the next 45 days. 




Propanc Biopharma Publishes Key Scientific Data in Peer Reviewed Journal

Thu, 19 Oct 2017 07:49:17 EDT

Pancreatic Proenzymes Provides For Potent Anti-Tumor Efficacy in Pancreatic and Ovarian Cancers




BioCorRx to Exhibit at the International Association of Chiefs of Police 2017 Annual Conference in Philadelphia

Thu, 19 Oct 2017 07:30:00 EDT

ANAHEIM, CA--(Marketwired - Oct 19, 2017) - BioCorRx, Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that the Company will have an exhibit at the International Association of Chiefs of Police (IACP) 2017 Annual Conference at the Pennsylvania Convention Center in Philadelphia, Pennsylvania on October 21-24th.




Preparing for Phase II: Finding the Right Dose, Schedule, and Combination from your Phase I/II Oncology Clinical Trial, New Webinar Hosted by Xtalks

Thu, 19 Oct 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - October 19, 2017) - In a complimentary webinar, experts from Premier Research Paul Hallenbeck, Ph.D., Executive Director of Strategic Development, Oncology, Peter Larson, M.D., Senior Medical Director of Hematology-Oncology and Gabriele Accetta, Principal Biostatistician discuss important factors for planning and executing early-phase oncology clinical trials in preparation for a decision-making Phase II trial. The live event takes place on Tuesday, November 7, 2017 at 11am EST (4pm GMT).




RenalGuard Solutions ernennt Andrew Halpert zum Chief Technology Officer

Wed, 18 Oct 2017 10:12:51 EDT

MILFORD, MA--(Marketwired - 18. Oktober 2017) - RenalGuard Solutions, Inc., ein Medizintechnikunternehmen, das sich auf innovative Technologie für den Herz- und Gefäße-Markt konzentriert, gab heute die Beförderung von Andrew Halpert zur Position des Chief Technology Officer bekannt.




RenalGuard Solutions nomme Andrew Halpert au poste de directeur de la technologie

Wed, 18 Oct 2017 10:09:05 EDT

MILFORD, MA--(Marketwired - 18 octobre 2017) - RenalGuard Solutions, Inc., un fabricant d'appareils médicaux axé sur des technologies innovantes pour les marchés cardiaque et vasculaire, a annoncé aujourd'hui la promotion d'Andrew Halpert au poste de directeur de la technologie.




Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions

Wed, 18 Oct 2017 09:22:37 EDT

Companies Will Combine PBI's Recently Patented Ultra Shear Technology with Phasex's Supercritical Fluid Processing Methods to Enable Development of Stable, Water-Soluble Nanoemulsions, Including CBD-Enriched Plant Oil




Advantis Corp. Finalizes Oregon Contract, Accepts Bitcoin From Some New Customers

Wed, 18 Oct 2017 09:20:00 EDT

NEWPORT BEACH, CA--(Marketwired - Oct 18, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) finalized the deal with a private cannabis grower in Oregon to supply Amster-Can canning and branding services. Advantis is shipping the original canning equipment to Oregon to fulfill orders at full production capacity. As Advantis grows its client base, it has decided to accept Bitcoin as payment from clients that prefer this mode of payment.




Medovex Corporation to Participate in World's Largest Spine Exhibition, NASS 2017

Wed, 18 Oct 2017 08:30:00 EDT

Company to Host Surgical Innovation Cadaver Lab with Key European and U.S. Thought Leaders for the DenerveX(R) System Technology




Spectral Announces Retirement of Chief Financial Officer

Wed, 18 Oct 2017 08:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Oct. 18, 2017) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) a Phase III Company advancing a precision treatment targeting specific patients at high risk of death from endotoxemic septic shock, today announced that Tony Businskas will be retiring as the Executive Vice President and CFO of the Company on January 31, 2018, after 12 years of service to the Company.




Simple and Cost-effective Ways to Engage Patients Using eCOA and IRT Systems, New Webinar Hosted by Xtalks

Wed, 18 Oct 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - October 18, 2017) - This webinar will focus on how sponsors and CROs can use IRT and eCOA systems to promote patient engagement through features which reinforce compliance and retention, as well as functionality that allows for sharing information with patients throughout a clinical trial.




Building Smart Biomedical Devices Using Glass, Lasers, Sensors, and Chips - New Webinar Hosted by Xtalks

Wed, 18 Oct 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - October 18, 2017) - This webinar will explain how Glass Core Technology will lead customers to new products with a higher level of integration and more innovative features that result in smart biomedical devices and other emerging technologies. The live broadcast takes place on Friday, November 3, 2017 at 11am EDT (3pm GMT), with featured speaker Steve Groothuis, Chief Technology Officer for Samtec Microelectronics.




Rand Capital Portfolio Company, OnCore Golf, Announces Project Launch for Genius Ball(TM)

Tue, 17 Oct 2017 16:15:00 EDT

OnCore Golf refers to the Genius Ball(TM) as the "Ball with a Brain"




The Journey from Passive to Active TMF with C.R. Bard, Inc. and Daiichi Sankyo, New Webinar Hosted by Xtalks

Tue, 17 Oct 2017 13:04:48 EDT

As the industry move to eTMF continues at a pace, hear from two organizations about their journeys to optimize clinical trial processes and the benefits they are seeing from making the shift to active TMF




RenalGuard Solutions Names Andrew Halpert Chief Technology Officer

Tue, 17 Oct 2017 11:23:13 EDT

MILFORD, MA--(Marketwired - October 17, 2017) - RenalGuard Solutions, Inc., a medical device company focused on innovative technologies for the cardiac and vascular markets, today announced the promotion of Andrew Halpert to the position of Chief Technology Officer.




The Hydropothecary Corporation Engages CFN Media to Develop New Investor Audience

Tue, 17 Oct 2017 09:30:00 EDT

SEATTLE, WA--(Marketwired - Oct 17, 2017) - CFN Media Group ("CFN Media", "CannabisFN"), the leading agency and digital media network dedicated to the North American cannabis industry, today announced that The Hydropothecary Corporation (TSX VENTURE: THCX) has engaged CFN Media to conduct a 3-month investor and market visibility program beginning on October 16th, 2017.




Abattis Offers a Solution to Canada's Cannabis Pesticide Problem -- CFN Media

Tue, 17 Oct 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Oct 17, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (CNSX: ATT) (CNSX: ATT.CN) (OTCQB: ATTBF), whose wholly-owned subsidiary is one of the only publicly-traded third-party cannabis testing laboratories. A steady stream of cannabis recalls has prompted regulators in Canada to call for the mandatory testing of cannabis for unauthorized pesticides. With only a handful of third-party laboratories licensed to test cannabis, these service providers are becoming increasingly important.




The Journey from Passive to Active TMF with C.R. Bard, Inc. and Daiichi Sankyo, New Webinar Hosted by Xtalks

Tue, 17 Oct 2017 07:30:00 EDT

As the industry move to eTMF continues at a pace, hear from two organizations about their journeys to optimize clinical trial processes and the benefits they are seeing from making the shift to active TMF




BioCorRx CEO Brady Granier Appears on MichaeLA on HLN to Discuss Alcohol Addiction

Tue, 17 Oct 2017 07:00:00 EDT

ANAHEIM, CA--(Marketwired - Oct 17, 2017) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, President & CEO of BioCorRx, appeared as a guest on MichaeLA hosted by Michaela Pereira live from CNN's Los Angeles bureau, to discuss alcohol addiction and the BioCorRx® Recovery Program, which works to help people suffering from alcohol and opioid abuse disorders. The segment can be viewed in the News & Media section of the BioCorRx website. To find out more information on the BioCorRx Recovery Program please visit www.beataddiction.com.




How Leveraging an Asia-Pacific Network Can Create Regional Efficiencies in Clinical Supply Management, New Webinar Hosted by Xtalks

Tue, 17 Oct 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - October 17, 2017) - The session will examine how to leverage the major clinical supply centers of China, Singapore and Japan to support clinical trials within the Asia-Pacific region for both local and global study sponsors, with featured speaker Daniel Gao, Site Director of Catalent's Clinical Supply Services in Shanghai. There will be two live broadcasts on Tuesday, October 31, 2017, at 10am EDT (2pm GMT/UK) and on Wednesday November 1, 2017, at 10am CST, 7:30am IST (11am JST and 1pm AEDT).




Medigus Receives First Purchase Order From Izasa Hospital in Spain for Its MUSE System

Tue, 17 Oct 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Oct 17, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that Izasa Hospital, S.L.U., a distributor of medical products in the hospital sector, has provided an initial purchase order (PO) for the Medigus Ultrasonic Surgical Endostapler, or MUSET system. The PO covers the cost of a MUSET system console and endoscopic device, which will be available for use on patients suffering from gastroesophageal reflux disease (GERD).




The Alliance for Regenerative Medicine Releases Agenda for Fifth Annual 2017 European Advanced Therapies Investor Day

Tue, 17 Oct 2017 04:00:00 EDT

LONDON, UNITED KINGDOM and WASHINGTON, DC--(Marketwired - Oct 17, 2017) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, along with co-hosts UK BioIndustry Association (BIA) and the Cell and Gene Therapy Catapult, releases the agenda for its annual European Advanced Therapies Investor Day, to be held November 9, 2017 in London.




MobileHelp(R) Healthcare Appoints Jerriene Cordova as Director of Telehealth Programs, Telehealth

Mon, 16 Oct 2017 16:38:57 EDT

BOCA RATON, FL--(Marketwired - October 16, 2017) - MobileHelp® Healthcare, a leader in mobile Personal Emergency Response System (mPERS) and health management solutions, today announced the appointment of Jerriene Cordova as Director of Telehealth Programs. Ms. Cordova brings more than two decades of experience in developing new markets and building strategic alliances.




MobileHelp(R) Features Tablet-based Telehealth Solution at NAHC 2017

Mon, 16 Oct 2017 16:32:41 EDT

MobileVitals Touch system pairs remote patient monitoring with medical alert technology to optimize patient safety and medical oversight




Vendor Oversight: Five Best Practices in Optimizing Limited Resources

Mon, 16 Oct 2017 10:00:00 EDT

TORONTO, ON--(Marketwired - October 16, 2017) - In an Xtalks clinical trials webinar upcoming on Wednesday, October 18, 2017 experts will share industry trends in optimizing internal resources, and five best practices to maximize productivity, manage time and budget, and achieve actionable, accurate clinical Intelligence when working with internal and external teams.




Enacomm to Elevate Bank Independent Customer Experience with AI Assisted Banking

Mon, 16 Oct 2017 09:00:00 EDT

Demonstrating AI assisted banking at Jack Henry Annual Conference in Nashville this week




Athletes Free to Embrace CBD After WADA Decision - But There's a Catch -- CFN Media

Mon, 16 Oct 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Oct 16, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the World Anti-Doping Agency's (WADA) recent decision to remove cannabidiol (CBD) from its list of banned substances in 2018, and that decision's ramifications for Medical Marijuana Inc.'s (OTC PINK: MJNA) subsidiary, HempMeds®.




BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain

Mon, 16 Oct 2017 08:30:00 EDT

FREDERICK, MD--(Marketwired - Oct 16, 2017) - BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce the commencement of a clinical study investigating the efficacy of ActiPatch in treating chronic musculoskeletal lower back pain. Low back pain is highly prevalent and affects 1 in 3 adult Americans, accounting for about $ 90 billion in direct spending every year.




INmune Bio Appoints Edgardo Baracchini to its Board of Directors, Gains Additional Licensing and Business Development Expertise

Mon, 16 Oct 2017 08:30:00 EDT

LA JOLLA, CA--(Marketwired - Oct 16, 2017) - INmune Bio, Inc., a cancer immunotherapy company focused on developing therapies that harness the patient's innate immune system to attack their cancer, today announces the appointment of Edgardo "Ed" Baracchini, PhD. to its board of directors. Dr. Baracchini, the Chief Business Officer of Xencor since 2010, brings transactional and business development expertise that is well-aligned with INmune Bio's expanding product portfolio.




Efficiently Managing Your Drug Supply Beyond IRT, New Webinar Hosted by Xtalks

Mon, 16 Oct 2017 08:22:47 EDT

TORONTO, ON--(Marketwired - October 16, 2017) - In a complimentary webinar taking place on Monday, October 30, 2017 at 1 p.m. EDT, industry expert Brett Castano, Senior Architect of Project Management at endpoint Clinical, will examine how sponsors can manage their clinical trails more efficiently.




Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue

Mon, 16 Oct 2017 07:30:00 EDT

Anticipates Over 90% Year-over-Year Revenue Growth in the Third Quarter and Cash Flow Breakeven around Year-End




Specific Cardiovascular issues in Oncology Drug Development, New Webinar Hosted by Xtalks

Mon, 16 Oct 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - October 16, 2017) - On October 24-25, 2017 scientific experts will be gathering at the CSRC/FDA Annual Meeting to discuss cardiac risk management and safety assessment in oncology drug development. BioTelemetry Research's Chief Medical Officer, Polina Voloshko, MD, and Vice President and Medical Director, Daniel Goodman, MD, will be attending. As a follow up to this meeting, Drs. Voloshko, and Goodman will be providing a complimentary webinar, broadcasting live on Wednesday, November 1, 2017 at 11:00am EDT, on the Key Takeaways from the upcoming CSRC/FDA Annual Meeting on Cardiac Safety and Cardiovascular Safety Issues in Oncology Drug Development.




Imagin Medical Closing Second and Final Tranche of $1,000,000 Private Placement

Fri, 13 Oct 2017 12:07:19 EDT

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery; The Company's initial focus is bladder cancer




Streetwise Reports Examines How a Telemedicine Platform Is Gaining Traction in Fast Growing Market

Fri, 13 Oct 2017 09:00:00 EDT

SAN FRANCISCO, CA--(Marketwired - October 13, 2017) - Telemedicine lies in the forefront of innovation for the healthcare industry. Using a combination of telecommunications and technology, healthcare can be provided from a distance, providing essential coverage to people in rural communities, among others, who may not have ready access to medical facilities.




Daily Diabetes Management in the Virtual World, New Webinar Hosted by Xtalks

Fri, 13 Oct 2017 08:13:42 EDT

TORONTO, ON--(Marketwired - October 13, 2017) - In a live broadcast upcoming on Tuesday, October 17, 2017 at 11am EDT (4pm BST.UK), guest speakers from PRA Health Sciences and Sanofi will provide insight into how they worked with patients with diabetes to gather information and how they used a Design Thinking Methodology approach for insight and prototype generation.




NEMUS Bioscience Provides Further Update on Previously Announced $20 Million Schneider Financing

Fri, 13 Oct 2017 08:00:00 EDT

COSTA MESA, CA--(Marketwired - Oct 13, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) (the "Company") today announced a further update to its news releases dated May 4, 2017 and July 11, 2017 with respect to the signing of a private placement with Schneider Finance LLC, an affiliate of Schneider Brothers Ltd, a global closed investment fund, for the sale of 1,000,000 shares of Series E Preferred Stock of the Company for gross proceeds of $20,000,000. As previously announced, SB Securities Ltd, an affiliate of Schneider Brothers Ltd, entered into a guaranty to the benefit of the Company that guarantees the payment of the $20,000,000 investment.




Endonovo Receives Positive Results from Pre-Clinical Study of Non-Invasive Electroceutical

Fri, 13 Oct 2017 07:30:00 EDT

Non-Invasive Electroceutical Significantly Increased Cardiac Function and Reduced Ventricular Remodeling in Infarcted Animals